| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 05.01. | Perspective Therapeutics, Inc.: Perspective Therapeutics Announces Exclusive License Agreement with Mayo Clinic for New Radiopharmaceutical Platform for Prostate Cancer Treatment | 180 | GlobeNewswire (Europe) | Mayo Clinic's PSMA Alpha-PET DoubLET platform allows for imaging and targeted therapy with alpha and/or beta-particle radiopharmaceutical therapy (RPT) using a novel 64/67Cu and 203/212Pb double... ► Artikel lesen | |
| 05.01. | Safeguard Scientifics Announces Effective Date of Stock Splits to Effectuate the Going Dark Transaction and New Chief Executive Officer and Chief Financial Officer | 263 | GlobeNewswire (Europe) | RADNOR, Pa., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Safeguard Scientifics, Inc. (Nasdaq:SFE) ("Safeguard" or the "Company") today announced that, as authorized by its Board of Directors (the "Board"),... ► Artikel lesen | |
| 05.01. | LumiraDx Limited: LumiraDx Announces its Securities will be Suspended from Trading on Nasdaq at the Open of Business on January 9th | 457 | GlobeNewswire (Europe) | LONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- LumiraDx Limited (Nasdaq: LMDX)(the "Company") today announced that it has received notification from The Nasdaq Stock Market LLC ("Nasdaq") that its securities... ► Artikel lesen | |
| 05.01. | AlphaTime Acquisition Corp.: AlphaTime Acquisition Corp Announces Entering into a Merger Agreement with HCYC Group Company Limited | 282 | GlobeNewswire (Europe) | New York, NY, Jan. 05, 2024 (GLOBE NEWSWIRE) -- AlphaTime Acquisition Corp (NASDAQ: ATMC, ATMCU, ATMCR, and ATMCW) ("ATMC"), a special purpose acquisition company, announced the execution of an Agreement... ► Artikel lesen | |
| 05.01. | Apollo Silver Corp.: Apollo Announces Commencement of Management Transition | 332 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Apollo Silver Corp. ("Apollo" or the "Company") (TSX.V:APGO, OTCQB:APGOF, Frankfurt:6ZF0) reports that the Board of Directors of the... ► Artikel lesen | |
| 05.01. | ECARX Announces Board Changes | 227 | GlobeNewswire (Europe) | LONDON, Jan. 05, 2024 (GLOBE NEWSWIRE) -- ECARX Holdings Inc. (Nasdaq: ECX) ("ECARX" or the "Company"), a global mobility tech provider, today announced the appointment of Mr. Tan Su as a director... ► Artikel lesen | |
| 05.01. | Semantix, Inc.: Semantix Provides Update Regarding Nasdaq Minimum Bid Price Compliance | 517 | GlobeNewswire (Europe) | SÃO PAULO, Brazil, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Semantix, Inc. (NASDAQ: STIX), a leading Latin American enterprise AI platform and applications provider, today announced that on January 2, 2024... ► Artikel lesen | |
| 05.01. | Grupo Aeroportuario del Pacífico, S.A.B. de C.V.: Grupo Aeroportuario del Pacifico Reports in December 2023 a Passenger Traffic Increase of 2.2% Compared to 2022 | 202 | GlobeNewswire (Europe) | GUADALAJARA, Mexico, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) ("the Company" or "GAP") announces preliminary terminal passenger traffic... ► Artikel lesen | |
| 05.01. | Apellis Pharmaceuticals, Inc.: Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 131 | GlobeNewswire (Europe) | WALTHAM, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc. (Nasdaq: APLS) today announced that the company approved the grant of equity awards to 2 new employees with a grant... ► Artikel lesen | |
| 05.01. | Tempest Therapeutics: Tempest Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 329 | GlobeNewswire (Europe) | BRISBANE, Calif., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Tempest Therapeutics, Inc. (Nasdaq: TPST), a clinical-stage oncology company developing first-in-class1 therapeutics that combine both targeted... ► Artikel lesen | |
| 05.01. | Senti Biosciences, Inc.: Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program | 413 | GlobeNewswire (Europe) | - Strategic resource allocation to focus investment on clinical development of SENTI-202 and SENTI-301A partnership in China; interim data from Phase 1 clinical trial of SENTI-202 expected in 2H 2024... ► Artikel lesen | |
| 05.01. | Tango Therapeutics, Inc.: Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 188 | GlobeNewswire (Europe) | BOSTON, Mass., Jan. 05, 2024 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision... ► Artikel lesen | |
| 05.01. | PMV Pharmaceuticals, Inc.: PMV Pharmaceuticals Strengthens Leadership with Key Appointments as Company Advances into Late-Stage Development | 484 | GlobeNewswire (Europe) | PC14586 clinical program to be led by Deepika Jalota, Pharm.D. (Chief Development Officer) and Marc Fellous, M.D. (Senior Vice President, Head of Clinical Development and Medical Affairs)Michael Carulli... ► Artikel lesen | |
| 05.01. | Barinthus Biotherapeutics: Barinthus Bio Provides a Financial Update and Announces Anticipated 2024 Corporate Milestones | 233 | GlobeNewswire (Europe) | Cash runway anticipated to be extended from Q2 2025 to Q4 2025Data from multiple Phase 1 and 2 clinical trials expected in 2024 OXFORD, United Kingdom, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Barinthus... ► Artikel lesen | |
| 05.01. | BioCryst Pharmaceuticals, Inc.: BioCryst Announces Preliminary Full Year 2023 ORLADEYO (berotralstat) Net Revenue of $325 Million, Provides 2024 Guidance and Accelerated Path to Profitability | 146 | GlobeNewswire (Europe) | -ORLADEYO preliminary 2023 full year net revenue of $325 million (+29 percent y-o-y)- -ORLADEYO net revenue expected to be between $380-$400 million in 2024, on trajectory for $1 billion in peak... ► Artikel lesen | |
| 05.01. | Molecular Partners and Orano Med Announce Co-Development Agreement for Radio-DARPin Therapies | 257 | GlobeNewswire (Europe) | Collaboration leverages lead-based (212Pb) alpha emitter expertise and supply of Orano Med with Molecular Partners' leadership in DARPins for tumor-targeted delivery of radioactive payloadsCo-Development... ► Artikel lesen | |
| 05.01. | Oryzon Genomics, S.A.: ORYZON Announces Topline Results from Phase IIb PORTICO Study of Vafidemstat in Borderline Personality Disorder (BPD) | 247 | GlobeNewswire (Europe) | Company to host Conference Call and live Webcast on Sunday, January 7, 2024 at 5:30 pm PT. An executive summary of the data to be presented at the 7th Sachs Annual Neuroscience Innovation Forum,... ► Artikel lesen | |
| 05.01. | SBM Offshore N.V.: FPSO Sepetiba producing and on hire | 886 | GlobeNewswire (Europe) | January 5, 2024
SBM Offshore is pleased to announce that FPSO Sepetiba is formally on hire as of January 2, 2024 after achieving first oil and the completion of a 72-hour continuous production test... ► Artikel lesen | |
| 05.01. | SPINEWAY: Shares reverse split | 2.697 | GlobeNewswire (Europe) | Press release Ecully, January 5, 2024 - 6.00 pm Reverse split of Spineway shares Reverse split by exchange of 2,000 existing shares for 1 new shareStart of share split period: January 25... ► Artikel lesen | |
| 05.01. | StoneCo Ltd.: StoneCo Announces SCFI License | 656 | GlobeNewswire (Europe) | GEORGETOWN, Cayman Islands, Jan. 05, 2024 (GLOBE NEWSWIRE) -- StoneCo Ltd. (Nasdaq: STNE; B3: STOC31) ("Stone" or the "Company") today announced that it received from the Brazilian Central Bank ("BCB")... ► Artikel lesen |
Seite:
1 2 3 4 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| SUPER MICRO COMPUTER | 3.983 |
| EVOTEC | 3.178 |
| TUI | 2.803 |
| NVIDIA | 2.734 |
| BAYER | 2.659 |
| NEL | 2.469 |
| RENK GROUP | 1.788 |
| RHEINMETALL | 1.704 |
| TESLA | 1.302 |
| PALANTIR TECHNOLOGIES | 1.279 |
| VOLKSWAGEN | 1.265 |
| DEUTSCHE BANK | 1.151 |
| PLUG POWER | 1.068 |
| AMAZON | 1.043 |
| BYD | 1.043 |
| MICROSTRATEGY | 1.042 |
| PROSIEBENSAT.1 | 1.028 |
| BASF | 1.020 |
| COMMERZBANK | 1.019 |
| MERCEDES-BENZ | 948 |
| THYSSENKRUPP | 935 |
| JINKOSOLAR | 888 |
| ALLIANZ | 886 |
| AIXTRON SE | 879 |
| DEUTSCHE TELEKOM | 874 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
